CAS 150405-69-9|3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
Introduction：Basic information about CAS 150405-69-9|3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole | ||
|---|---|---|---|
| CAS Number | 150405-69-9 | Molecular Weight | 429.556 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 611.5±58.0 °C at 760 mmHg |
| Molecular Formula | C30H27N3 | Melting Point | 231-235 ℃ |
| MSDS | ChineseUSA | Flash Point | 323.6±32.3 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 611.5±58.0 °C at 760 mmHg |
| Melting Point | 231-235 ℃ |
| Molecular Formula | C30H27N3 |
| Molecular Weight | 429.556 |
| Flash Point | 323.6±32.3 °C |
| Exact Mass | 429.220490 |
| PSA | 30.71000 |
| LogP | 9.55 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.615 |
| InChIKey | ZVFQEOPUXVPSLB-UHFFFAOYSA-N |
| SMILES | CC(C)(C)c1ccc(-c2nnc(-c3ccc(-c4ccccc4)cc3)n2-c2ccccc2)cc1 |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| RIDADR | NONH for all modes of transport |
Articles57
More Articles| Inhibitory mechanism of FAT4 gene expression in response to actin dynamics during Src-induced carcinogenesis. PLoS ONE 10(2) , e0118336, (2015) Oncogenic transformation is characterized by morphological changes resulting from alterations in actin dynamics and adhesive activities. Emerging evidence suggests that the protocadherin FAT4 acts as ... | |
| Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets. Oncotarget 5(23) , 12166-76, (2015) Triple-negative breast cancer (TNBC) accounts for approximately 15-20% of all breast cancer (BC) cases and contributes disproportionately to BC mortality. TAZ, a key transducer of the Hippo pathway, h... | |
| Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis. Cell Cycle 14(1) , 146-56, (2015) The Hippo pathway is an evolutionarily conserved regulator of tissue growth and cell fate during development and regeneration. Conversely, deregulation of the Hippo pathway has been reported in severa... |
Synonyms
| 3-(4-Biphenylyl)-5-[4-(2-methyl-2-propanyl)phenyl]-4-phenyl-4H-1,2,4-triazole |
| 4H-1,2,4-Triazole, 3-[1,1'-biphenyl]-4-yl-5-[4-(1,1-dimethylethyl)phenyl]-4-phenyl- |
| 3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole |
| 3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole |
| 3-(4-BiPhenyl)-4-Phenyl-5-Tert-butylPhenyl-1,2,4-Triazole |
